Login with your work email address to view charts. No credit card required.
| Art Unit: | 2677 — Image analysis |
|---|---|
| Group: | 2660-2670 — Image Analysis; Applications; pattern Recognition; Color and Compression; Enhancement and Transformation |
| Classes: |
382 — Image analysis 600 — Surgery 706 — Data processing: artificial intelligence 705 — Data processing: financial, business practice, management, or cost/price determination 351 — Optics: eye examining, vision testing and correcting 702 — Data processing: measuring, calibrating, or testing 700 — Data processing: generic control systems or specific applications |
| Phone: | (571) 272-3475 |
| Email: | winta.gebreslassie@uspto.gov |
| Location: | VA 22314 |
| Title: | Pat Examnr(Biomedical Engrg) |
| Service: | 6 years |
| Grade: | GS-12 |
| 3-Year Grant rate: | 77% over 98 cases |
|---|---|
| Difficulty: | Medium |
| Difficulty Percentile: | 49th
|
With Examiner Gebreslassie, you have a 77% chance of getting an issued patent by 3 years after the first office action. Examiner Gebreslassie is a medium examiner and in the 49th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Gebreslassie, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Gebreslassie's grant rate is lower than that of Art Unit 2677 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Gebreslassie | 1.7 |
| Art Unit 2677 | 1.2 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.